Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence

Tahrir Alenezi,Bilal Alrubaye,Ying Fu,Janashrit Shrestha,Samar Algehani,Hong Wang,Rohana Liyanage,Xiaolun Sun
DOI: https://doi.org/10.3390/pathogens13060464
IF: 3.7
2024-05-31
Pathogens
Abstract:Clostridium perfringens is the main pathogen of chicken necrotic enteritis (NE) causing huge economic losses in the poultry industry. Although dietary secondary bile acid deoxycholic acid (DCA) reduced chicken NE, the accumulation of conjugated tauro-DCA (TDCA) raised concerns regarding DCA efficacy. In this study, we aimed to deconjugate TDCA by bile salt hydrolase (BSH) to increase DCA efficacy against the NE pathogen C. perfringens. Assays were conducted to evaluate the inhibition of C. perfringens growth, hydrogen sulfide (H2S) production, and virulence gene expression by TDCA and DCA. BSH activity and sequence alignment were conducted to select the bsh gene for cloning. The bsh gene from Bifidobacterium longum was PCR-amplified and cloned into plasmids pET-28a (pET-BSH) and pDR111 (pDR-BSH) for expressing the BSH protein in E. coli BL21 and Bacillus subtilis 168 (B-sub-BSH), respectively. His-tag-purified BSH from BL21 cells was evaluated by SDS-PAGE, Coomassie blue staining, and a Western blot (WB) assays. Secretory BSH from B. subtilis was analyzed by a Dot-Blot. B-sub-BSH was evaluated for the inhibition of C. perfringens growth. C. perfringens growth reached 7.8 log10 CFU/mL after 24 h culture. C. perfringens growth was at 8 vs. 7.4, 7.8 vs. 2.6 and 6 vs. 0 log10 CFU/mL in 0.2, 0.5, and 1 mM TDCA vs. DCA, respectively. Compared to TDCA, DCA reduced C. perfringens H2S production and the virulence gene expression of asrA1, netB, colA, and virT. BSH activity was observed in Lactobacillus johnsonii and B. longum under anaerobe but not L. johnsonii under 10% CO2 air. After the sequence alignment of bsh from ten bacteria, bsh from B. longum was selected, cloned into pET-BSH, and sequenced at 951 bp. After pET-BSH was transformed in BL21, BSH expression was assessed around 35 kDa using Coomassie staining and verified for His-tag using WB. After the subcloned bsh and amylase signal peptide sequence was inserted into pDR-BSH, B. subtilis was transformed and named B-sub-BSH. The transformation was evaluated using PCR with B. subtilis around 3 kb and B-sub-BSH around 5 kb. Secretory BSH expressed from B-sub-BSH was determined for His-tag using Dot-Blot. Importantly, C. perfringens growth was reduced greater than 59% log10 CFU/mL in the B-sub-BSH media precultured with 1 vs. 0 mM TDCA. In conclusion, TDCA was less potent than DCA against C. perfringens virulence, and recombinant secretory BSH from B-sub-BSH reduced C. perfringens growth, suggesting a new potential intervention against the pathogen-induced chicken NE.
microbiology
What problem does this paper attempt to address?
The main problem this paper attempts to address is: improving the inhibitory efficiency of taurodeoxycholic acid (TDCA) on *Clostridium perfringens* virulence by expressing recombinant bile salt hydrolase (BSH). Specifically, the research background is as follows: - *Clostridium perfringens* is the primary pathogen causing necrotic enteritis (NE) in chickens, resulting in an economic loss of approximately $6 billion annually to the poultry industry. - Bile acids, particularly deoxycholic acid (DCA), have been shown to reduce the incidence of necrotic enteritis in chickens. However, the accumulation of TDCA in the intestine has raised concerns about its effectiveness. - Researchers aim to enhance the inhibitory effect of TDCA on *Clostridium perfringens* by expressing recombinant BSH to deconjugate TDCA into DCA. To achieve this goal, the researchers conducted the following experiments: 1. **Evaluate the effects of TDCA and DCA on the growth of *Clostridium perfringens*, hydrogen sulfide (H2S) production, and virulence gene expression**: - The results showed that TDCA had a weaker inhibitory effect on *Clostridium perfringens* compared to DCA. DCA significantly reduced the growth of *Clostridium perfringens*, H2S production, and the expression of virulence genes. 2. **Clone and express the BSH gene**: - The bsh gene was cloned from *Bifidobacterium longum* and the BSH protein was expressed in *E. coli* and *Bacillus subtilis*. 3. **Evaluate the activity of recombinant BSH**: - The expression and purification of the BSH protein were verified using SDS-PAGE, Coomassie Brilliant Blue staining, and Western Blot. 4. **Evaluate the inhibitory effect of recombinant BSH on the growth of *Clostridium perfringens***: - *Bacillus subtilis* expressing BSH (B-sub-BSH) was pre-cultured in media containing different concentrations of TDCA, and its inhibitory effect on the growth of *Clostridium perfringens* was assessed. The results showed that B-sub-BSH significantly reduced the growth of *Clostridium perfringens*. In summary, this study aims to improve the inhibitory effect of TDCA on *Clostridium perfringens* by expressing recombinant BSH, thereby providing a new strategy for the prevention and treatment of necrotic enteritis in chickens.